D
David Cohen
Researcher at Pierre-and-Marie-Curie University
Publications - 787
Citations - 45536
David Cohen is an academic researcher from Pierre-and-Marie-Curie University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 83, co-authored 635 publications receiving 37722 citations. Previous affiliations of David Cohen include University of California, Berkeley & University of Michigan.
Papers
More filters
Journal ArticleDOI
Prolonged hallucinations and dissociative self mutilation following use of Salvia divinorum in a bipolar adolescent girl
Jean-Jacques Breton,Christophe Huynh,Sylvie Raymond,Réal Labelle,N. Bonnet,David Cohen,Jean-Marc Guilé +6 more
TL;DR: The clinical case of a bipolar 17-year-old girl who developed prolonged vivid hallucinations and a dissociative state involving self-destructive behaviour following the use of Salvia divinorum is presented, suggesting that the recreational use of the herb may result in serious psychiatric consequences in vulnerable individuals.
Journal ArticleDOI
Intérêt de l’abord sensorimoteur dans les pathologies autistiques sévères. II : illustration clinique
TL;DR: In this paper, the authors propose an illustration clinique partant du bilan sensorimoteur initial comme cle de voute des options therapeutiques en psychomotricite, decidee a raison de deux seances hebdomadaires en salle and en piscine.
Journal ArticleDOI
In‐hospital and one year outcomes with drug‐eluting versus bare metal stents in large native coronary arteries: A report from the evaluation of drug‐eluting stents and ischemic events registry
Paul C. Gordon,David Cohen,Neal S. Kleiman,Jay A. Montgomery,Christopher A. Semder,Kevin F. Kennedy,Michelle J. Keyes,Robert N. Piana,Robert N. Piana +8 more
TL;DR: The objective was to compare the clinical outcomes after perctuaneous coronary revascularization of large coronary arteries using drug‐eluting (DES) or bare‐metal (BMS) stents.
Journal ArticleDOI
Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC trial)
TL;DR: Hospitalizations after primary PCI are so short, however, that efforts to accelerate discharge with abciximab appear unfeasible, and overall costs remain unchanged.
Journal ArticleDOI
Does experimental research support psychoanalysis
TL;DR: It can be concluded that there are no discrepancies between psychodynamic views and experimental data, whether one tests psychotherapeutic approaches, discusses data from other fields such as psychopharmacology, or designs experiments based on psychodynamic theory.